Zimmer Biomet Holdings Inc
$ 88.57
1.64%
12 Jun - close price
- Market Cap 16,875,733,000 USD
- Current Price $ 88.57
- High / Low $ 88.78 / 86.92
- Stock P/E 22.60
- Book Value 65.53
- EPS 3.86
- Next Earning Report 2026-08-06
- Dividend Per Share $0.96
- Dividend Yield 1.1 %
- Next Dividend Date 2026-07-31
- ROA 0.04 %
- ROE 0.06 %
- 52 Week High 107.45
- 52 Week Low 79.12
About
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Analyst Target Price
$98.70
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-28 | 2026-02-10 | 2025-11-05 | 2025-08-07 | 2025-05-05 | 2025-02-06 | 2024-10-30 | 2024-08-07 | 2024-05-02 | 2024-02-08 | 2023-11-07 | 2023-08-01 |
| Reported EPS | 2.09 | 2.42 | 1.16 | 0.77 | 0.91 | 2.31 | 1.74 | 2.01 | 1.94 | 2.2 | 1.65 | 1.82 |
| Estimated EPS | 1.86 | 2.4 | 0.93 | 1.18 | 0.87 | 2.29 | 1.74 | 1.99 | 1.87 | 2.16 | 1.6 | 1.81 |
| Surprise | 0.23 | 0.02 | 0.23 | -0.41 | 0.04 | 0.02 | 0 | 0.02 | 0.07 | 0.04 | 0.05 | 0.01 |
| Surprise Percentage | 12.3656% | 0.8333% | 24.7312% | -34.7458% | 4.5977% | 0.8734% | 0% | 1.005% | 3.7433% | 1.8519% | 3.125% | 0.5525% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.99 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-30 | 2026-01-30 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 |
| Amount | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 |
Next Dividend Records
| Dividend per share (year): | $0.96 |
| Dividend Yield | 1.1% |
| Next Dividend Date | 2026-07-31 |
| Ex-Dividend Date | 2026-06-25 |
Recent News: ZBH
2026-06-13 08:49:48
First National Bank of Omaha recently acquired a new stake of 98,467 shares, valued at approximately $8.92 million, in Zimmer Biomet Holdings, Inc. during the fourth quarter. This move is part of broader institutional interest, with several other hedge funds also increasing their holdings in the medical equipment provider, bringing total institutional ownership to 88.89%. Despite this, analysts maintain a cautious "Hold" rating with a consensus target price of $102.70 for Zimmer Biomet.
2026-06-12 20:39:14
NeuroOne Medical Technologies Corporation has restated its Q2 2026 financial results due to duplicated revenue and cost entries, leading to a reduction in product revenue and gross profit. The company reported a significant net loss and reiterated substantial doubt about its ability to continue as a going concern, projecting that current funds will only last through September 2026. This restatement highlights a control deficiency in revenue processes and underscores high customer concentration risk.
2026-06-12 11:44:51
Sector Gamma AS increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 16.7% in the fourth quarter, now owning 132,478 shares valued at $11,912,000. Several other institutional investors also adjusted their holdings. Wall Street analysts currently have a consensus "Hold" rating on Zimmer Biomet, with an average price target of $102.70.
2026-06-12 09:25:37
Parnassus Investments LLC increased its stake in Edwards Lifesciences Corporation by 23.6% in the fourth quarter, acquiring an additional 111,843 shares. This raises their total holdings to 586,760 shares, valued at approximately $50,021,000. Other institutional investors also adjusted their positions, and analysts generally maintain a "Moderate Buy" rating for the stock.
2026-06-12 08:08:46
Equity Investment Corp reduced its stake in Zimmer Biomet Holdings, Inc. by 7.5% in the fourth quarter of 2025, selling 108,509 shares and retaining 1.33 million shares valued at approximately $119.9 million. This adjustment makes Zimmer Biomet the 12th largest holding for the firm, representing 2.4% of its investment portfolio. The medical equipment provider recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and announced a quarterly dividend of $0.24 per share.
2026-06-11 20:08:25
BTIG analysts highlight Stryker's Mako robotic system as a leading platform for ambulatory surgery centers (ASCs), driven by increasing surgeon and patient demand for robotic-assisted procedures. The report, following a healthcare conference, notes the shift of robotics from discretionary to necessary technology, supported by flexible contract structures. Despite a challenging reimbursement environment, augmented reality and advances in biologics and total disc replacement are identified as key innovation catalysts.
